InvestorsHub Logo
Followers 17
Posts 2036
Boards Moderated 1
Alias Born 09/27/2020

Re: Sloan89RH post# 129883

Sunday, 11/28/2021 3:33:20 PM

Sunday, November 28, 2021 3:33:20 PM

Post# of 130515
That's why I want to be invested in both. I've hit my target share count for Todos. Now it's time to start buying Amarantus because most investors haven't made the connection, unless they watched one of Gerald's recent videos where he spelled out his plans for Amarantus rebirth via the uplist where the 78M shares of TOMDF will fund Amarantus' clinical trials of their assets going forward. Some feel he has abandoned Amarantus, but I disagree. One company's success can benefit the other, but both can't be done simultaneously as both companies require capital in order to move forward.

While Todos share price is expected to move significantly higher once their Tollovir phase 2 interim data is released, Amarantus would be the longer play here, and price is certainly right for loading up several hundred thousand or million shares and sitting on it for a year to see how it plays out. I know some who never sold their AMBS shares and are anticipating this strategy as well.

GLTA